meta_pixel
Tapesearch Logo
Log in
The People's Pharmacy

Show 1338: What 80+ Years of Research Tell Us About Happiness

The People's Pharmacy

Joe and Terry Graedon

Health & Fitness, Alternative Health, Kids & Family, Medicine

4.61.2K Ratings

🗓️ 20 April 2023

⏱️ 67 minutes

🧾️ Download transcript

Summary

Have you ever wondered what makes for a meaningful life? Philosophers have debated this for centuries, but now science has something to add. The current director of the Harvard Study of Adult Development shares the findings from this long-running, in-depth research on the factors that lead to happiness and a meaningful life.

80+ Years of Science:

The Harvard Study of Adult Development started with Harvard undergraduates in 1938. Before too long, the study expanded to include young men from underprivileged families in Boston. Over the decades, the researchers contacted not only the 724 original volunteers, but also their partners and their children to invite them to participate as well. The detailed questionnaires they filled out periodically provide a great deal of data on the factors that make for a good life. As the study proceeded, new methods also became available. In addition to chronicling the volunteers’ physical and mental health, their work life and relationships, the researchers also collected information on the performance of their hearts on a stress test, the length of their telomeres and their DNA.

Can Money Buy Happiness?

Having such different sources for the initial cohorts allowed the scientists to examine the role of resources in shaping a meaningful life. What they found is that once basic needs are met, having more money does not make a person happier. As the Beatles sang, “Money can’t buy me love.”  Consequently, privilege does not determine happiness.

Defining Happiness:

There are at least two common ways to understand happiness. The first is the delight you might find in a hot fudge sundae. While hot fudge might not be your thing, everyone appreciates a bit of pleasure from time to time, whether it is the sight of sun shining through green leaves or the sound of a perfectly tuned wind chime. This hedonic happiness is short-lived.

Another approach is eudaimonic happiness. This is longer-term, and might best be explained as finding a way to make life meaningful. For the participants in the study, connections with other people were a keystone.

Nurturing Relationships Is the Secret to Happiness:

Some of the most miserable people in the study found ways to blame their partners or colleagues for their disappointments. Others derived great satisfaction from their relationships. Although the investigators found that trauma can take away our trust in the world, that can be restored if people have supportive relationships later with trustworthy people.

Generalizing broadly, study volunteers have two important pieces of advice for the rest of us:
1. Take care of your body as if you’ll need it for 100 years.
2. Take care of your relationships and remember that the community depends upon each of us.

Are We in Control of our Own Happiness?

Our culture glorifies extroverts, especially when the topic is relationships. Even though the party animals may do well in building lots of relationships, quieter, more introverted people with a few strong friendships can also thrive.

Dr. Sonja Lyubomirsky has examined the question of what accounts for happiness. Her research indicates that perhaps 50 percent can be attributed to inborn temperament, while at least 40 percent is under our own control. Luck also plays a role. Happiness is an accident, but we can make ourselves more accident-prone in this regard.

This Week’s Guest:

Robert Waldinger, MD, is a professor of psychiatry at Harvard Medical School, director of the Harvard Study of Adult Development at Massachusetts General Hospital, and cofounder of the Lifespan Research Foundation. Dr. Waldinger received his AB from Harvard College and his MD from Harvard Medical School. He is a practicing psychiatrist and psychoanalyst, and he directs a psychotherapy teaching program for Harvard psychiatry residents. He is also a Zen master (Roshi) and teaches meditation in New England and around the world. Robert is the co-author, with Marc Schulz, PhD, of the book The Good Life: Lessons From the World’s Longest Scientific Study on Happiness.

Listen to the Podcast:

The podcast of this program will be available Monday, April 24, 2023, after broadcast on April 22. You can stream the show from this site and download the podcast for free.

Download the mp3.

Transcript

Click on a timestamp to play from that location

0:00.0

I'm Joe Gradyton and I'm Terry Grady. Welcome to this podcast of the People's Pharmacy.

0:06.1

You can find previous podcasts and more information on a range of health topics at people's pharmacy.com.

0:15.0

For centuries philosophers have been debating what makes a good life.

0:20.0

Now a long-running study offers answers.

0:23.2

This is the People's Pharmacy with Terry and Joe Grayden. Since 1938, the Harvard Study of Adult Development has periodically contacted its original

0:40.5

cohorts and their partners in offspring.

0:43.6

Almost all of these people filled out detailed questionnaires.

0:48.0

What does science show us about the factors that produce happiness? One key to a meaningful life is connecting with other people

0:56.0

and paying attention to their needs, not just your own.

1:00.0

How much of our happiness is under our control?

1:04.0

Coming up on the People's Pharmacy, whatlines, the Food and Drug Administration has just announced that it's authorized a second byvalent booster vaccination for at-risk individuals.

1:25.0

That includes people over 65 and immunocompromised patients.

1:30.0

The Pfizer Bioin Tech and Moderna Bivalent Boosters will protect against the original COVID-19 virus,

1:37.6

as well as the Omicron BA-4 and B-A-5 strains. Older Americans can get a second bivalient booster if at least four

1:45.8

months have passed since their first booster. Those who are immunocompromised need wait only

1:51.8

two months following a prior booster.

1:54.6

The FDA is recommending that vulnerable populations consider a second booster because immunity

2:00.4

fades after several months, and the second shot can reestablish some protection.

2:06.0

The Institute for Clinical and Economic Review, or ICER, has just issued a report questioning the value of the newest Alzheimer disease drug.

2:17.5

The FDA approved Lekemby, known by the generic name the Canomab in January. At the time headlines proclaimed the drug

2:26.1

an important advance in the treatment of dementia, but the new report

2:31.1

titled Beta Amyloid Antoid antibodies for early Alzheimer's disease paints a far less rosy picture.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Joe and Terry Graedon, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Joe and Terry Graedon and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.